ACTIVATED eEF2K PROTEINS AND THEIR USE.
CCNY Ranajeet Ghose & UT Austin (ntd): Kevin Dalby.
This engineered protein enables identification of novel allosteric activators or inhibitors of the kinase. These will have potential therapeutic value for treating cancer or other diseases associated with unregulated protein synthesis.
NIH R01 GM123252.
For more information or to license this innovation:
- Log In
to view the innovation's details
- Sign Up
with discount code "ECOS"
